annual current assets:
$1.09B+$338.92M(+45.41%)Summary
- As of today (June 22, 2025), HALO annual total current assets is $1.09 billion, with the most recent change of +$338.92 million (+45.41%) on December 31, 2024.
- During the last 3 years, HALO annual current assets has risen by +$159.05 million (+17.17%).
- HALO annual current assets is now at all-time high.
Performance
HALO Current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current assets:
$1.26B+$176.69M(+16.28%)Summary
- As of today (June 22, 2025), HALO quarterly total current assets is $1.26 billion, with the most recent change of +$176.69 million (+16.28%) on March 31, 2025.
- Over the past year, HALO quarterly current assets has increased by +$388.44 million (+44.47%).
- HALO quarterly current assets is now at all-time high.
Performance
HALO quarterly current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
HALO Current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.4% | +44.5% |
| 3 y3 years | +17.2% | +27.6% |
| 5 y5 years | +99.7% | +169.7% |
HALO Current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.9% | at high | +132.9% |
| 5 y | 5-year | at high | +99.7% | at high | +169.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
HALO Current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.26B(+16.3%) |
| Dec 2024 | $978.14M(-0.9%) | $1.09B(-3.7%) |
| Sep 2024 | - | $1.13B(+14.1%) |
| Jun 2024 | - | $987.80M(+13.1%) |
| Mar 2024 | - | $873.58M(+17.0%) |
| Dec 2023 | $986.85M(-10.5%) | $746.42M(-15.1%) |
| Sep 2023 | - | $879.01M(+14.8%) |
| Jun 2023 | - | $765.75M(+24.5%) |
| Mar 2023 | - | $615.02M(-16.8%) |
| Dec 2022 | $1.10B(+518.9%) | $739.01M(+13.1%) |
| Sep 2022 | - | $653.20M(+20.5%) |
| Jun 2022 | - | $541.94M(-45.2%) |
| Mar 2022 | - | $988.69M(+6.7%) |
| Dec 2021 | $178.14M(+608.0%) | $926.29M(-8.9%) |
| Sep 2021 | - | $1.02B(+1.8%) |
| Jun 2021 | - | $999.75M(+6.2%) |
| Mar 2021 | - | $941.72M(+69.8%) |
| Dec 2020 | $25.16M(+12.1%) | $554.76M(+11.2%) |
| Sep 2020 | - | $498.89M(-0.3%) |
| Jun 2020 | - | $500.36M(+6.9%) |
| Mar 2020 | - | $467.97M(-13.9%) |
| Dec 2019 | $22.44M(+81.0%) | $543.44M(+58.9%) |
| Sep 2019 | - | $342.04M(-12.7%) |
| Jun 2019 | - | $391.71M(-4.2%) |
| Mar 2019 | - | $409.04M(-4.4%) |
| Dec 2018 | $12.40M(+29.5%) | $427.85M(-0.5%) |
| Sep 2018 | - | $429.93M(-6.9%) |
| Jun 2018 | - | $462.03M(-4.6%) |
| Mar 2018 | - | $484.47M(-5.1%) |
| Dec 2017 | $9.57M(+92.1%) | $510.37M(+44.4%) |
| Sep 2017 | - | $353.35M(+3.7%) |
| Jun 2017 | - | $340.83M(+53.3%) |
| Mar 2017 | - | $222.35M(-13.3%) |
| Dec 2016 | $4.98M(-50.3%) | $256.53M(-5.9%) |
| Sep 2016 | - | $272.61M(-4.1%) |
| Jun 2016 | - | $284.34M(-4.3%) |
| Mar 2016 | - | $297.04M(+72.9%) |
| Dec 2015 | $10.02M(+115.1%) | $171.77M(+12.2%) |
| Sep 2015 | - | $153.09M(-9.1%) |
| Jun 2015 | - | $168.44M(+9.9%) |
| Mar 2015 | - | $153.33M(-5.0%) |
| Dec 2014 | $4.66M(-29.4%) | $161.32M(+1.7%) |
| Sep 2014 | - | $158.60M(-9.7%) |
| Jun 2014 | - | $175.62M(-8.0%) |
| Mar 2014 | - | $190.91M(+100.6%) |
| Dec 2013 | $6.60M | $95.19M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $102.82M(+2.4%) |
| Jun 2013 | - | $100.42M(-9.6%) |
| Mar 2013 | - | $111.11M(-14.9%) |
| Dec 2012 | $4.10M(+131.5%) | $130.63M(+23.7%) |
| Sep 2012 | - | $105.62M(-11.8%) |
| Jun 2012 | - | $119.73M(-9.7%) |
| Mar 2012 | - | $132.57M(+107.2%) |
| Dec 2011 | $1.77M(-4.1%) | $63.99M(-16.9%) |
| Sep 2011 | - | $76.97M(-12.5%) |
| Jun 2011 | - | $88.01M(+11.1%) |
| Mar 2011 | - | $79.19M(-11.5%) |
| Dec 2010 | $1.85M(-31.8%) | $89.50M(-9.1%) |
| Sep 2010 | - | $98.43M(+99.6%) |
| Jun 2010 | - | $49.32M(-21.3%) |
| Mar 2010 | - | $62.68M(-15.8%) |
| Dec 2009 | $2.71M(+6.2%) | $74.44M(-10.7%) |
| Sep 2009 | - | $83.41M(-10.9%) |
| Jun 2009 | - | $93.65M(+41.5%) |
| Mar 2009 | - | $66.18M(-10.6%) |
| Dec 2008 | $2.55M(+11.7%) | $74.01M(-5.4%) |
| Sep 2008 | - | $78.23M(-9.2%) |
| Jun 2008 | - | $86.12M(-10.9%) |
| Mar 2008 | - | $96.62M(-4.5%) |
| Dec 2007 | $2.28M(+358.7%) | $101.18M(-6.4%) |
| Sep 2007 | - | $108.08M(+5.0%) |
| Jun 2007 | - | $102.94M(+40.5%) |
| Mar 2007 | - | $73.29M(+60.8%) |
| Dec 2006 | $497.80K(+23.2%) | $45.59M(+163.1%) |
| Sep 2006 | - | $17.33M(+5.3%) |
| Jun 2006 | - | $16.45M(-11.5%) |
| Mar 2006 | - | $18.58M(-7.6%) |
| Dec 2005 | $404.10K(+56.6%) | $20.11M(+189.8%) |
| Sep 2005 | - | $6.94M(-34.2%) |
| Jun 2005 | - | $10.55M(-22.1%) |
| Mar 2005 | - | $13.54M(-16.1%) |
| Dec 2004 | $258.00K(>+9900.0%) | $16.15M(+347.2%) |
| Sep 2004 | - | $3.61M(-40.1%) |
| Jun 2004 | - | $6.03M(-20.4%) |
| Mar 2004 | - | $7.57M(+1402.9%) |
| Dec 2003 | - | $503.60K(+666.5%) |
| Sep 2003 | - | $65.70K(-9.5%) |
| Jun 2003 | - | $72.60K(-21.1%) |
| Mar 2003 | - | $92.00K(-17.7%) |
| Sep 2002 | - | $111.80K(-8.7%) |
| Jun 2002 | - | $122.50K(+223.2%) |
| Mar 2002 | - | $37.90K |
| Dec 2001 | $0.00 | - |
FAQ
- What is Halozyme Therapeutics annual total current assets?
- What is the all time high annual current assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual current assets year-on-year change?
- What is Halozyme Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly current assets year-on-year change?
What is Halozyme Therapeutics annual total current assets?
The current annual current assets of HALO is $1.09B
What is the all time high annual current assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual total current assets is $1.09B
What is Halozyme Therapeutics annual current assets year-on-year change?
Over the past year, HALO annual total current assets has changed by +$338.92M (+45.41%)
What is Halozyme Therapeutics quarterly total current assets?
The current quarterly current assets of HALO is $1.26B
What is the all time high quarterly current assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly total current assets is $1.26B
What is Halozyme Therapeutics quarterly current assets year-on-year change?
Over the past year, HALO quarterly total current assets has changed by +$388.44M (+44.47%)